Avantax Advisory Services, Inc. Dr Reddys Laboratories LTD Transaction History
Avantax Advisory Services, Inc.
- $14.9 Billion
- Q3 2024
A detailed history of Avantax Advisory Services, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 22,742 shares of RDY stock, worth $307,471. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,742
Previous 22,678
0.28%
Holding current value
$307,471
Previous $1.73 Million
4.57%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
252Shares Held
34.4MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$155 Million0.35% of portfolio
-
Morgan Stanley New York, NY2.24MShares$30.3 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$27 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$26.4 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$24.4 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.24B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...